Target intelligence / Profile preview

RNA-binding protein 28 (RBM28)

Target
RBM28
Molecular classification
RNA-binding protein, Nucleolar protein, Component of spliceosomal small nuclear ribonucleoprotein (snRNP) complexes
01

Overview

RNA-binding protein 28 (RBM28) is a specific nucleolar component of the spliceosomal small nuclear ribonucleoprotein complexes, uniquely associating with multiple snRNAs (U1, U2, U4, U5, U6) and potentially coordinating their transition through the nucleolus[1][5][3]. It responds to nucleolar stress and may move between cellular compartments to modulate the activity of proteins such as p53[9]. Mutations in RBM28 are associated with a rare syndrome characterized by alopecia, neurological defects, and endocrinopathies (ANE syndrome)[1][3]. There is no evidence that RBM28 is a direct target for current therapeutic drugs, nor are any biomarkers or mechanisms of drug action documented for this protein[3][9].

Other names
RNA binding motif protein 28FLJ10377NOP4ANES2810480G15Rik
02

Biological functions

Spliceosomal small nuclear ribonucleoprotein assemblyRNA splicingAssociation with U1, U2, U4, U5, U6 small nuclear RNA (snRNA)Nucleolar stress response
03

Disease associations

Alopecia, neurologic defects, and endocrinopathy syndrome (ANE syndrome)
04

Safety considerations

Biallelic mutations cause ANE syndrome with pleiotropic clinical effects[3][1]

Beyond the preview

Go deeper on RNA-binding protein 28 (RBM28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA-binding protein 28 (RBM28).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call